Antianalgesic action of dynorphin a mediated by spinal cholecystokinin (44361)

Experimental Biology and Medicine

Volumn 220, Issue 3, 1999, Pages 178-183

  Rady, Jodie J ^a   Holmes, Blythe B ^a   Fujimoto, James M ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DELTA OPIATE RECEPTOR AGONIST; DYNORPHIN A; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; LORGLUMIDE; MORPHINE; PD 135158;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SPINAL CORD; TAIL FLICK TEST;

ANALGESIA; ANALGESICS; ANIMALS; ANTIBODIES; CHOLECYSTOKININ; DYNORPHINS; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALIN, LEUCINE; ENKEPHALINS; INDOLES; INJECTIONS, SPINAL; MALE; MEGLUMINE; MICE; MORPHINE; PROGLUMIDE; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, OPIOID, DELTA; SPINAL CORD;

ANIMALIA;

EID: 0033061819     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.1999.d01-26.x     Document Type: Article

References (14)

1. Wang FS, Fujimoto JM. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice. J Pharmacol Exp Ther 265:1361-1368, 1993.
2. Rady JJ, Lin W, Fujimoto JM. Pentobarbital antagonism of morphine analgesia mediated by spinal cholecystokinin. J Pharmacol Exper Ther 284:878-885, 1998.
3. B receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat. J Pharmacol Exp Ther 278:90-98, 1996.
4. Urban MO, Smith DJ. Localization of the antinociceptive and antian algesic effects of neurotensin within the rostral ventromedial medulla. Neurosci Lett 174:21-25, 1994.
5. Urban MO, Smith DJ. Role of neurotensin in the nucleus raphe magnus in opioid-induced antinociception from the periaqueductal gray. J Pharmacol Exp Ther 265:580-586, 1993.
6. Paris PL, Komisaruk BR, Watkins LR, Mayer DJ. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 219:310-312, 1983.
7. Kellstein DE, Price DD, Mayer DJ. Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphine-induced inhibition of C-fiber evoked discharges of dorsal horn nociceptive neurons. Brain Res 540:302-306, 1991.
8. Watkins LR, Kinscheck IB, Kaufman EF, Miller J, Frenk H, Mayer DJ. Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates. Brain Res 327:181-190, 1985.
9. Watkins LR, Kinscheck IB, Mayer DJ. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide. Brain Res 327:169-180, 1985.
10. Fujimoto JM, Schaus Arts K, Rady JJ, Tseng LF. Spinal dynorphin A (1-17): Possible mediator of antianalgesic action in mice. Neuropharmacol 29:609-617, 1990.
11. Wang FS, Rady JJ, Fujimoto JM. Elimination of the antianalgesic action of dynorphin A (1-17) by spinal transsection in barbital anesthetized mice. J Pharmacol Exp Ther 268:873-880, 1994.
12. Rady JJ, Holmes BB, Fujimoto JM. Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A. Pharmacol Biochem Behav 60:1-10, 1998.
13. D'Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79, 1941.
14. Dewey WL, Harris LS, Howes JF, Nuite JA. The effect of various neurohormonal modulators on the activity of morphine and the narcotic antagonists in the tail flick and phenylquinone test. J Pharmacol Exp Ther 175:435-442, 1970.